Publications

Joint publications:
ZORA Publication List
Download Options
Publications
-
New and emerging roles of small RNAs in neurodegeneration, muscle, cardiovascular and inflammatory diseases Swiss Medical Weekly:w14192.
Table of contents
Aguzzi Group
ZORA Publication List
Download Options
Publications
-
Autoantibodies against the prion protein in individuals with PRNP mutations Neurology, 95(14):e2028-e2037.
-
Protective anti‐prion antibodies in human immunoglobulin repertoires EMBO Molecular Medicine:e12739.
-
Genome-wide transcriptomics identifies an early preclinical signature of prion infection PLoS Pathogens, 16(6):e1008653.
-
NG2 glia are required for maintaining microglia homeostatic state Glia:glia.23721.
-
Unaltered prion disease in mice lacking developmental endothelial locus–1 Neurobiology of Aging, 76:208-213.
-
SARM1 deficiency up-regulates XAF1, promotes neuronal apoptosis, and accelerates prion disease Journal of Experimental Medicine:jem.20171885.
-
Genome-Wide Identification of microRNAs Regulating the Human Prion Protein Brain Pathology, 29(2):232-244.
-
Toxic Protein Spread in Neurodegeneration: Reality versus Fantasy Trends in Molecular Medicine, 24(12):1007-1020.
-
Prion pathogenesis is unaltered in a mouse strain with a permeable blood-brain barrier PLoS Pathogens, 14(11):e1007424.
-
Prions, prionoids and protein misfolding disorders Nature Reviews. Genetics, 19(7):405-418.
-
Intrinsic Toxicity of Antibodies to the Globular Domain of the Prion Protein Biological Psychiatry, 84(7):e51-e52.
-
GPR56/ADGRG1 regulates development and maintenance of peripheral myelin Journal of Experimental Medicine, 215(3):941-961.
-
Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity PLoS Pathogens, 13(11):e1006733.
-
Absolute Quantification of Amyloid Propagons by Digital Microfluidics Analytical Chemistry, 89(22):12306-12313.
-
Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling PLoS ONE, 12(5):e0177876.
-
The biological function of the cellular prion protein: an update BMC Biology, 15:34.
-
Modifiers of prion protein biogenesis and recycling identified by a highly-parallel endocytosis kinetics assay Journal of Biological Chemistry, 292(20):8356-8368.
-
Cystatin F is a biomarker of prion pathogenesis in mice PLoS ONE, 12(2):e0171923.
-
Neurotoxic antibodies against the prion protein do not trigger prion replication PLoS ONE, 11(9):e0163601.
-
The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6 Nature, 536(7617):464-468.
-
A neuroprotective role for microglia in prion diseases Journal of Experimental Medicine, 213(6):1047-1059.
-
Phase separation: linking cellular compartmentalization to disease Trends in Cell Biology, 26(7):547-558.
-
Altered monoaminergic systems and depressive-like behavior in congenic prion protein nnock-out mice Journal of Biological Chemistry, 290(43):26350.
-
Structure-based drug design identifies polythiophenes as antiprion compounds Science Translational Medicine, 7(299):299ra123.
-
Neurodegeneration: Alzheimer's disease under strain Nature, 512(7512):32-34.
-
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation Nature Immunology, 15(8):727-737.
-
Strictly co-isogenic C57BL/6J-Prnp−/−mice: A rigorous resource for prion science Journal of Experimental Medicine, 213(3):313-327.
-
Differential toxicity of antibodies to the prion protein PLoS Pathogens, 12(1):e1005401.
-
Cell biology of prions and prionoids: a status report Trends in Cell Biology, 26(1):40-51.
-
Prion pathogenesis in the absence of NLRP3/ASC inflammasomes PLoS ONE, 10(2):e0117208.
-
Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways PLoS Pathogens, 11(2):e1004662.
-
The role of the NADPH oxidase NOX2 in prion pathogenesis PLoS Pathogens, 10(12):e1004531.
-
Efficient amyloid a clearance in the absence of immunoglobulins and complement factors American Journal of Pathology, 182(4):1297-1307.
-
SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells Journal of Experimental Medicine, 210(12):2539-2552.
-
Prions and lymphoid organs: Solved and remaining mysteries Prion, 7(2):157-163.
-
The immunobiology of prion diseases Nature Reviews. Immunology, 13(12):888-902.
-
The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein Nature, 501(7465):102-106.
-
Prions: protein aggregation and infectious diseases Physiological Reviews, 89(4):1105-1152.
Krützfeldt Group
ZORA Publication List
Download Options
Publications
-
Uncoupling protein 1 expression in adipocytes derived from skeletal muscle fibro/adipogenic progenitors is under genetic and hormonal control Journal of Cachexia, Sarcopenia and Muscle, 9(2):384-399.
-
Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance Journal of Molecular Medicine, 93(12):1369-1379.
-
Strategies to use microRNAs as therapeutic targets Best Practice & Research : Clinical Endocrinology & Metabolism, 30(5):551-561.
Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005 Dec 1;438(7068):685-9.
Krützfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet. 2006 Jun;38 Suppl 1:S14-9.
Krützfeldt J, Stoffel M. MicroRNAs: A new class of regulatory genes affecting metabolism. Cell Metab. 2006 Jul;4(1):9-12.
Krützfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T, Manoharan M, Stoffel M. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 2007 April; 35(9):2885-92.
Krützfeldt J, Rösch N, Hausser J, Manoharan M, Zavolan M, Stoffel M. MicroRNA-194 is a target of transcription factor 1 (Tcf1, Hnf1α) in adult liver and controls expression of frizzled-6. Hepatology. 2012 Jan;55(1):98-107.
Polymenidou Group
ZORA Publication List
Download Options
Publications
-
Prion-like propagation as a pathogenic principle in frontotemporal dementia Journal of Neurochemistry, 138 Supp:163-183.
Polymenidou M*, Lagier-Tourenne C*, Hutt KR*, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett CF, Yeo GW, Cleveland DW (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature Neurosc, 14, 459–468 [*equal contribution]
Polymenidou M, Cleveland DW (2011) The Seeds of Neurodegeneration: Prion-like Spreading in ALS. Cell, 147, 498-508
Polymenidou M, Cleveland DW (2012) Prion-like spread of protein aggregates in neurodegeneration. Journal of Exp Med, 209, 889-93
Lagier-Tourenne C*, Polymenidou M*, Hutt KR*, Vu AQ, Clutario K, Baughn M, Huelga SC, Ling SC, Liang TY, Mazur C, Wancewicz E, Kim AS, Watt A, Freier S, Hicks GG, Donohue JP, Shiue L, Bennett CF, Ravits J, Cleveland DW and Yeo GW (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nature Neurosc, 15, 1488-97 [*equal contribution]
Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, Qiu J, Sun Y, Ling S-C, Zhu Q, Polymenidou M, Drenner K, Artates JW, McAlonis-Downes M, Markmiller S, Hutt KR, Pizzo DP, Cady J, Harms MB, Baloh RH, Vandenberg SR, Yeo GW, Fu X-D, Bennett CF, Cleveland DW, Ravits J (2013) Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. PNAS, 110, 47, E4530-39
Stoffel Group
LaPierre MP and Stoffel M (2017). MicroRNAs as stress regulators in pancreatic beta cells and diabetes. Molecular Metabolism 6:1010-1023.
Landmesser Group
ZORA Publication List
Download Options
Publications
-
Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs Arteriosclerosis, Thrombosis, and Vascular Biology, 33(6):1392-1400.
-
Role of microRNAs in stem/progenitor cells and cardiovascular repair Cardiovascular Research, 93(4):614-622.
Shroff, R. et al. HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype. Journal of the American Society of Nephrology : JASN 25, 2658-2668, doi:10.1681/ASN.2013111212 (2014).
Landmesser, U. Coronary artery disease: HDL and coronary heart disease--novel insights. Nature reviews. Cardiology 11, 559-560, doi:10.1038/nrcardio.2014.128 (2014).
Kratzer, A., Giral, H. & Landmesser, U. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease. Cardiovascular research 103, 350-361, doi:10.1093/cvr/cvu139 (2014).
Krankel, N., Luscher, T. F. & Landmesser, U. Novel insights into vascular repair mechanisms. Current pharmaceutical design 20, 2430-2438 (2014).
Kyburz Group
Kyburz D, Karouzakis E, Ospelt C. Epigenetic changes: the missing link. Best Pract Res Clin Rheumatol. 2014 Aug;28(4):577-587.